Nanalysis Announces First Quarter 2026 Results

• Q1 2026 Financial Performance: Nanalysis reported Q1 2026 revenue of $10.7 million, a marginal 1% increase year-over-year (YoY). Adjusted EBITDA improved to $292 thousand, up 62% from the $180 thousand in Q1 2025.
• Segment Performance: Security Services revenue grew 18% YoY to $5.9 million, with gross margins expanding significantly from 6% to 19%. Conversely, Product Sales dropped 41% YoY to $2.179 million due to lower NMR benchtop demand and termination of third-party contracts.
• Capital Actions: The company utilized proceeds from a January 2026 equity financing to repay approximately $3.4 million in debt ($2.1M term loan + $1.3M line of credit).
• Operational Updates: European sales presence expanded, with distributor-led sales representing 45% of benchtop NMR sales. Board changes included the appointment of three new directors and the departure of Martin Burien and Jennifer Stubbs.
• Outlook: Management reiterated expectations for improved operational performance through 2026, citing cost optimization and service contract growth.

• Validation of Guidance: The Q1 results align with management's April 2026 guidance to expect "stronger 2026 performance." Revenue stabilization (+1%) after a year of double-digit declines (FY 2025 down 12%, Q3/Q4 2025 down ~12-13%) confirms the turnaround narrative but does not exceed expectations significantly.
• Margin Improvement: The Security Services margin expansion from 6% to 19% is a positive operational indicator, suggesting better cost control or pricing power in that segment. However, this improvement is partially offset by the collapse in Product Sales margins (down to 58% from 66%).
• Debt Reduction: The repayment of $3.4 million in debt reduces interest burden and improves balance sheet stability but was funded by a previously announced private placement ($3.4M raised in Dec/Jan). This is not new capital, merely the execution of prior plans.
• Net Loss Persistence: Despite EBITDA improvement, the Net Loss remains substantial at $1.28 million for the quarter. The company is still burning cash and has not reached profitability.
• Product Decline Risk: The 41% drop in Product Sales is a significant negative signal that offsets the service growth. This segment was historically a core revenue driver, and its contraction suggests underlying demand issues or strategic shifts that may limit upside potential.

• Business Model: Nanalysis operates in two primary segments: Scientific Instruments (Benchtop NMR spectrometers) and Security Services (Airport security maintenance).
• Flagship Project: The core technology is low-field Nuclear Magnetic Resonance (NMR) spectroscopy, used for quality control in pharmaceuticals, food, and materials.
• Strategic Partnerships: Recent integration with Wiley's KnowItAll software enhances data compatibility. A five-year distribution agreement exists for metal detection equipment (CEIA).
• Market Position: The company focuses on "democratizing" NMR technology through portable instruments but faces competition from established players and shifting demand in the scientific sector.